awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36270115-77683866-D5AA-42C9-899E-0E8DDCE9A2A2
Q36270115-77683866-D5AA-42C9-899E-0E8DDCE9A2A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270115-77683866-D5AA-42C9-899E-0E8DDCE9A2A2
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
P2860
Q36270115-77683866-D5AA-42C9-899E-0E8DDCE9A2A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270115-77683866-D5AA-42C9-899E-0E8DDCE9A2A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
015154f7559a0a7e6ab1c36a57dc78dfad175e13
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.